Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Mar 17:5:2050312117699146.
doi: 10.1177/2050312117699146. eCollection 2017.

Adverse effect profile comparison of pain regimens with and without intravenous acetaminophen in total hip and knee arthroplasty patients

Alyssa Gallipani  1 , A Scott Mathis  1 , Hoytin Lee Ghin  1 , Germin Fahim  2
Affiliations

Adverse effect profile comparison of pain regimens with and without intravenous acetaminophen in total hip and knee arthroplasty patients

Alyssa Gallipani et al. SAGE Open Med. .

Abstract

Background: The use of adjunct, non-opioid agents is integral for pain control following total hip and knee arthroplasty. Literature comparing safety profiles of intravenous acetaminophen versus opioids is lacking.

Objective: To determine whether there is a difference in frequency and type of adverse effects between intravenous acetaminophen-treated and non-intravenous acetaminophen-treated patients. Primary safety endpoints included any adverse effect noted in the electronic medical record post-surgically. Secondary endpoints included changes in laboratory values, vital signs, and pain scores.

Methods: This is a retrospective, matched, cohort study with data collected from electronic medical records. Adverse effects were collected from progress notes, nursing notes, and post-operative notes. Mean pain score was measured by the 11-point visual analog scale over a 72-h period.

Results: A total of 609 patients who underwent a total hip or knee replacement were included. In all, 406 patients were treated with intravenous acetaminophen, and 203 patients received medication management without intravenous acetaminophen. More patients treated with intravenous acetaminophen experienced an adverse effect compared to patients who did not receive intravenous acetaminophen (91.63% versus 84.73%; p = 0.012). Mean cumulative acetaminophen exposure was similar in the intravenous acetaminophen group (7704.89 ± 2558.6 versus 7260.1 ± 3016.09 mg; p = 0.07). Mean opioid use was similar in the intravenous acetaminophen group as compared to the non-intravenous acetaminophen group (209.61 ± 555.09 versus 163.89 ± 232.44 mg; p = 0.152). Significantly higher mean pain scores were found in the intravenous acetaminophen group during the 72-h post-surgery period as compared with non-intravenous acetaminophen-treated patients.

Conclusion: The increased utilization of intravenous acetaminophen in multimodal pain management did not result in an improved safety or tolerability profile or reduced opioid utilization in orthopedic patients.

Keywords: Pharmacoepidemiology/drug safety; anaesthesia/pain.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on acute pain management. Anesthesiology 2012; 116: 248–273. - PubMed
    1. World Health Organization. World Health Organization’s cancer pain ladder for adults, http://www.who.int/cancer/palliative/painladder/en/ (2016, accessed 2 February 2016).
    1. Viscusi ER, Singla N, Gonzalez A, et al. IV Acetaminophen improves pain management and reduces opioid requirements in surgical patients: a review of the clinical data and case-based presentations. Anesthesiol News 2012; 38: 1–8.
    1. Mallinckordt Pharmaceuticals. Ofirmev (package insert). St. Louis, OH: Mallinckrodt Pharmaceuticals, 2010.
    1. Johnson & Johnson. McNeil Consumer Healthcare announces plans for new drug dosing instructions for Tylenol® products, https://www.jnj.com/news/all/McNeil-Consumer-Healthcare-Announces-Plans-... (2011, accessed 23 May 2016).

LinkOut - more resources